Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-23

Clinical Trial Update: Efficacies of HDDT With or Without Bismuth vs Amoxicillin-metronidazole BQT for First-line H Pylori Eradication [Phase 4]

View source ↗

Summary

Phase 4 trial comparing high-dose dual therapy regimens for first-line Helicobacter pylori eradication, with or without bismuth, against amoxicillin-metronidazo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMOXICILLIN (AMOXICILLIN)
  • Bismuth subsalicylate (bismuth subsalicylate)
  • METRONIDAZOLE (Metronidazole)
  • Omeprazole (Omeprazole)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: COMPLETED